Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Pharmaceutical Development and Technology|January 13, 2022
Design and evaluation of erucic acid-phytosphingosine structured cationic nanoemulsions as a plasmid DNA delivery system against breast cancer cellsSelen İsar, Hasan Akbaba, Yiğit Şahİn, et al.Journal of Biomedical Materials Research. Part B, Applied Biomaterials|January 22, 2025
Microfluidics Based Particle and Droplet Generation for Gene and Drug Delivery ApproachesDeniz Onan, Melike Özder, Meryem İrem Sipahi, et al.Cell Reports|September 3, 2020
CD49a Regulates Cutaneous Resident Memory CD8+ T Cell Persistence and ResponseShannon K Bromley, Hasan Akbaba, Vinidhra Mani, et al.ACS Omega|January 2, 2023
Atezolizumab-Conjugated Poly(lactic acid)/Poly(vinyl alcohol) Nanoparticles as Pharmaceutical Part Candidates for RadiopharmaceuticalsMeliha Ekinci, Clenilton Costa Dos Santos, Luciana Magalhães Rebelo Alencar, et al.Nature Immunology|July 14, 2025
IL-4 impairs the formation of skin-resident memory CD8+ T cellsRut Mora-Buch, Maisie E Lake, Andrea Sama, et al.Trends in Biotechnology|November 28, 2025
Gene therapy strategies in tissue engineering: advances and applications for regenerative therapyHasan Akbaba, Lucy Homer, Thi Bao Tram Tran, et al.Archiv Der Pharmazie|June 3, 2020
Design, synthesis, and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compoundsHuseyin Istanbullu, Gulsah Bayraktar, Hasan Akbaba, et al.Drug Delivery and Translational Research|April 16, 2025
Enhancing vaccine stability in transdermal microneedle platformsSuman Pahal, Feifei Huang, Parbeen Singh, et al.European Journal of Medicinal Chemistry|December 28, 2022
Design, synthesis, in vitro - In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibitionHuseyin Istanbullu, Gulsah Bayraktar, Gulsah Karakaya, et al.ACS Nano|March 28, 2019
Radiation-Induced Targeted Nanoparticle-Based Gene Delivery for Brain Tumor TherapyGulsah Erel-Akbaba, Litia A Carvalho, Tian Tian, et al.Pageof 3